Turning Point Brands Reports Strong Q4 & FY 2025 Results Driven by 266% Modern Oral Sales Growth
TPB has more than doubled off its 52-week low of $51.481.
Summary
Turning Point Brands announced robust financial results for Q4 and full year 2025, highlighted by significant growth in its Modern Oral segment and substantial increases in consolidated net sales and net income.
Key Events · Earnings and Guidance · TPB
-
Strong Q4 & FY 2025 Performance
Consolidated net sales increased 29.2% in Q4 to $121.0 million and 28.4% for the full year to $463.1 million. GAAP net income surged 239.8% in Q4 to $8.2 million and 46.1% for the full year to $58.2 million.
-
Modern Oral Segment Drives Growth
Modern Oral net sales grew 266% in Q4 2025 to $41.3 million, representing 34% of total company net sales, up from 12% in Q4 2024.
-
2026 Modern Oral Revenue Guidance
The company expects full year 2026 Modern Oral Gross Revenue of $220-$240 million and Net Revenue of $180-$190 million.
-
Healthy Liquidity
Ended Q4 2025 with $222.8 million in cash and $290.1 million in total liquidity, with net debt of $77.2 million.
Analysis · TPB · Manufacturing
The company delivered impressive Q4 and full-year 2025 financial performance, with consolidated net sales increasing by nearly 30% and GAAP net income surging over 200% in Q4. This strong growth was primarily fueled by the Modern Oral segment, which saw a remarkable 266% increase in net sales, now accounting for a third of total company sales. While the Zig-Zag segment experienced a decline, the overall results demonstrate successful execution of the company's strategy to pivot towards higher-growth categories. The provided 2026 guidance for Modern Oral revenue further reinforces confidence in this strategic direction, positioning the company for continued expansion despite planned investments impacting near-term adjusted EBITDA.
At the time of this filing, TPB was trading at $125.09 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $51.48 to $146.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.